Incidence, mortality, and racial differences in peripartum cardiomyopathy.
about
Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babiesPeripartum cardiomyopathy: current state of knowledge, new developments and future directionsPeripartum cardiomyopathyA systematic review of validated methods for identifying heart failure using administrative dataGlobal, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Peripartum cardiomyopathy: an intriguing challenge. Case report with literature review.Peripartum cardiomyopathy: A puzzle closer to solution.Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: A 15-year nationwide population-based study in Asia.Practical management of peripartum cardiomyopathyBromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports.[Special features of peripartum cardiomyopathy in Africa: the case of Togo on a prospective study of 41 cases at Sylvanus Olympio University Hospital of Lome].Case report and mini literature review: anesthetic management for severe peripartum cardiomyopathy complicated with preeclampsia using sufetanil in combined spinal epidural anesthesia.Peripartum cardiomyopathy: the need for a national databasePeripartum cardiomyopathy: a current review.Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based studyPeripartum cardiomyopathy: a review.Clinical characteristics and risk factors for peripartum cardiomyopathy.Peripartum cardiomyopathy: a contemporary reviewMolecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.Heart failure in sub-Saharan Africa.Current understanding of peripartum cardiomyopathy.Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.Peripartum cardiomyopathy: moving towards a more central role of genetics[The heart during pregnancy].Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathyAfrican-American women have a higher risk for developing peripartum cardiomyopathyArticle Commentary: Acute Heart Failure: Is it Peripartum Cardiomyopathy or Not?Reviewing peripartum cardiomyopathy: current state of knowledge.The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.Remarks on the Prolactin Hypothesis of Peripartum CardiomyopathyCurrent state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.An update on peripartum cardiomyopathy.16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.Heart failure in pregnancy.Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.Incidence and prevalence of pregnancy-related heart disease.Pathophysiology and epidemiology of peripartum cardiomyopathy.Improving outcomes in peripartum cardiomyopathy.Peripartum cardiomyopathy: current knowledge and future directions.
P2860
Q24235585-DBDF0F72-AB92-4660-8F77-2CBEDC8C7267Q27001962-1A00AB15-6AA2-4CC3-9245-EEACC7518223Q27015972-9EC77255-4564-485D-B0E7-1AE868B5FA22Q27026648-CDD735BC-A7B2-44D0-A215-8671C768BD0BQ30409179-A539C449-A489-41D0-ACE0-2B427AB3E774Q30434271-6E250200-FB3E-43DB-8B27-78EDA46BFDC5Q33358118-366B7D42-8169-42A7-A990-866FFFF40D0FQ33672992-A263CE74-CE4D-4AEF-A49F-7DCE9B22A236Q33690735-BF6AC1DF-51FC-492B-BDF0-5F0A876C0A27Q33732241-F7807500-05C5-4825-8652-9961FE4109C7Q34307172-E7547192-B479-4B73-99F8-C7932AF7402EQ34474494-496666D0-5B4A-4DAC-AC31-C730D932372CQ34619305-D5A8522E-F2C3-49FB-9A51-013865E73623Q34729767-D95FC522-4CDA-44B2-8E09-1AA4C0582A85Q35022026-53D88D4B-5C21-4C29-8000-01A0D2B13FC8Q35820163-B7DF2A85-A0FA-4041-BAA7-638140C87FB9Q36292318-6CC4E452-71ED-4A91-BBC1-D6E333DF2C4FQ36694091-F24F40D2-9F7D-4C22-A7F5-79100FCDFAC2Q36701224-C23DD2BE-9D9B-4107-B960-C650A25738EDQ36853140-DC5255E0-4705-41B0-B5E6-341958AF8CD6Q36928528-1507F032-9819-45CC-934D-FDB1F74AAEC9Q37024378-DD8A76A5-7BFA-44DD-9A38-F301DF751896Q37090976-4D6E7086-CCDE-4E14-9872-EB3758A8DA45Q37190410-B7C27564-CCEC-46D6-B48E-8157E83D422FQ37242100-06B6F743-1916-49CD-9456-8382E734654CQ37250867-23BAE785-D8CE-4758-89F7-0E403CB79087Q37270195-AAD297FB-D09A-45BF-ABEE-E1858EFAED3EQ37315379-FB0784F7-20DB-44FA-B9EC-429411DF7285Q37445871-109054CE-C2C3-46B0-B1B9-8ADE32BEB996Q37597482-ED5D178F-972A-45D5-BDFB-17FA7BDDEDC8Q37747134-8D0D9C3E-0B9E-4605-90D1-52D5ABE330CEQ37776975-DBD77122-0ABB-4A85-BA7B-E013EDACC406Q37935775-FBF7625A-A607-404F-A296-0BB5B4A8C5ACQ38021361-6F1A8DA1-F10A-4297-9E54-905B50A098B1Q38028370-0211C970-7A38-4AE6-BD48-AFCDD3819559Q38158206-F645D398-70A5-4A21-AD63-3E7CBCD06FA8Q38181455-48601991-E8D5-45EA-84CD-810C3A2F9526Q38200908-2EE97BE5-B9AE-4047-8B94-7BAEEB89F304Q38451142-7DF3B0D6-0692-458B-BF30-2A02BFB20EABQ38561417-9E2EB62B-AE8F-42EC-8A6A-F969D5E56987
P2860
Incidence, mortality, and racial differences in peripartum cardiomyopathy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Incidence, mortality, and racial differences in peripartum cardiomyopathy.
@en
type
label
Incidence, mortality, and racial differences in peripartum cardiomyopathy.
@en
prefLabel
Incidence, mortality, and racial differences in peripartum cardiomyopathy.
@en
P2093
P1476
Incidence, mortality, and racial differences in peripartum cardiomyopathy.
@en
P2093
Albert Yuh-Jer Shen
Gagandeep K Sandhu
Jin-Wen Y Hsu
Michael B Jorgensen
Neil Parikh
Somjot S Brar
Steven S Khan
P304
P356
10.1016/J.AMJCARD.2007.02.092
P407
P577
2007-06-06T00:00:00Z